Andere Kunden interessierten sich auch für
![TNM Supplement 1993]( "TNM Supplement 1993")
TNM Supplement 199379,99 €![Histological Typing of Salivary Gland Tumours]( "Histological Typing of Salivary Gland Tumours")
Histological Typing of Salivary Gland Tumours40,99 €![Histological Typing of Urinary Bladder Tumours]( "Histological Typing of Urinary Bladder Tumours")
Histological Typing of Urinary Bladder Tumours40,99 €![Pathology of Melanocytic Nevi and Melanoma]( "Pathology of Melanocytic Nevi and Melanoma")
Pathology of Melanocytic Nevi and Melanoma115,99 €![Current Cancer Research 2006]( "Current Cancer Research 2006")
Current Cancer Research 200616,99 €![Histological Typing of Tumours of the Gallbladder and Extrahepatic Bile Ducts]( "Histological Typing of Tumours of the Gallbladder and Extrahepatic Bile Ducts")
Histological Typing of Tumours of the Gallbladder and Extrahepatic Bile Ducts79,99 €![Cancer Risks]( "Cancer Risks")
Cancer Risks79,99 €
This monograph is the result of an effort by the International Union Against Cancer (UICC) to study prognostic factors related to cancer. It is an extension of the long-term work on the TNM Classification, the most widely used staging classification and the strongest prognostic tool for most cancers. The purpose of the monograph is to compile information on prognostic factors for most tumor sites and selected tumor types. Each site- or tumor-specific chapter provides a general overview of the relevant literature on prognostic factors. Where possible, the authors have attempted to assess these factors in terms of their clinical relevance and of their strength and independence in influencing prognosis.
M. K. Gospodarowicz, P. Hermanek, and D. E. Henson Attention to innovations in cancer treatment has tended to eclipse the importance of prognostic assessment. However, the recognition that prognostic factors often have a greater impact on outcome than available therapies and the proliferation of biochemical, molecular, and genetic markers have resulted in renewed interest in this field. The outcome in patients with cancer is determined by a combination of numerous factors. Presently, the most widely recognized are the extent of disease, histologic type of tumor, and treatment. It has been known for some time that additional factors also influence outcome. These include histologic grade, lymphatic or vascular invasion, mitotic index, performance status, symptoms, and most recently genetic and biochemical markers. It is the aim of this volume to compile those prognostic factors that have emerged as important determinants of outcome for tumors at various sites. This compilation represents the first phase of a more extensive process to integrate all prognostic factors in cancer to further enhance the prediction of outcome following treatment. Certain issues surround ing the assessment and reporting of prognostic factors are also considered. Importance of Prognostic Factors Prognostic factors in cancer often have an immense influence on outcome, while treatment often has a much weaker effect. For example, the influence of the presence of lymph node involvement on survival of patients with metastatic breast cancer is much greater than the effect of adjuvant treatment with tamoxifen in the same group of patients [5].
M. K. Gospodarowicz, P. Hermanek, and D. E. Henson Attention to innovations in cancer treatment has tended to eclipse the importance of prognostic assessment. However, the recognition that prognostic factors often have a greater impact on outcome than available therapies and the proliferation of biochemical, molecular, and genetic markers have resulted in renewed interest in this field. The outcome in patients with cancer is determined by a combination of numerous factors. Presently, the most widely recognized are the extent of disease, histologic type of tumor, and treatment. It has been known for some time that additional factors also influence outcome. These include histologic grade, lymphatic or vascular invasion, mitotic index, performance status, symptoms, and most recently genetic and biochemical markers. It is the aim of this volume to compile those prognostic factors that have emerged as important determinants of outcome for tumors at various sites. This compilation represents the first phase of a more extensive process to integrate all prognostic factors in cancer to further enhance the prediction of outcome following treatment. Certain issues surround ing the assessment and reporting of prognostic factors are also considered. Importance of Prognostic Factors Prognostic factors in cancer often have an immense influence on outcome, while treatment often has a much weaker effect. For example, the influence of the presence of lymph node involvement on survival of patients with metastatic breast cancer is much greater than the effect of adjuvant treatment with tamoxifen in the same group of patients [5].